These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 21878572)
1. Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma. Végran F; Boidot R; Bonnetain F; Cadouot M; Chevrier S; Lizard-Nacol S Endocr Relat Cancer; 2011 Dec; 18(6):783-92. PubMed ID: 21878572 [TBL] [Abstract][Full Text] [Related]
2. Distinct expression of Survivin splice variants in breast carcinomas. Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy. Boidot R; Vegran F; Lizard-Nacol S Int J Mol Med; 2009 Feb; 23(2):285-91. PubMed ID: 19148555 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy. Végran F; Boidot R; Oudin C; Riedinger JM; Bonnetain F; Lizard-Nacol S Clin Cancer Res; 2006 Oct; 12(19):5794-800. PubMed ID: 17020986 [TBL] [Abstract][Full Text] [Related]
5. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer. Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456 [TBL] [Abstract][Full Text] [Related]
6. Integrated gene expression profile predicts prognosis of breast cancer patients. Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552 [TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453 [TBL] [Abstract][Full Text] [Related]
8. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823 [TBL] [Abstract][Full Text] [Related]
9. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas. Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755 [TBL] [Abstract][Full Text] [Related]
10. [RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells]. Liang CY; Ma P; Liu XL Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1703-6. PubMed ID: 19024543 [TBL] [Abstract][Full Text] [Related]
11. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736 [TBL] [Abstract][Full Text] [Related]
12. ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpression. Yang W; Klos KS; Zhou X; Yao J; Yang Y; Smith TL; Shi D; Yu D Cancer; 2003 Sep; 98(6):1123-30. PubMed ID: 12973835 [TBL] [Abstract][Full Text] [Related]
13. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Tanaka K; Iwamoto S; Gon G; Nohara T; Iwamoto M; Tanigawa N Clin Cancer Res; 2000 Jan; 6(1):127-34. PubMed ID: 10656440 [TBL] [Abstract][Full Text] [Related]
14. Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy. Parton M; Krajewski S; Smith I; Krajewska M; Archer C; Naito M; Ahern R; Reed J; Dowsett M Clin Cancer Res; 2002 Jul; 8(7):2100-8. PubMed ID: 12114409 [TBL] [Abstract][Full Text] [Related]
15. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia. Tröger A; Siepermann M; Mahotka C; Wethkamp N; Bülle H; Laws HJ; Escherich G; Janka-Schaub G; Göbel U; Dilloo D Klin Padiatr; 2007; 219(3):127-33. PubMed ID: 17525905 [TBL] [Abstract][Full Text] [Related]
16. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385 [TBL] [Abstract][Full Text] [Related]
17. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients. Bottini A; Berruti A; Bersiga A; Brizzi MP; Brunelli A; Gorzegno G; DiMarco B; Aguggini S; Bolsi G; Cirillo F; Filippini L; Betri E; Bertoli G; Alquati P; Dogliotti L Clin Cancer Res; 2000 Jul; 6(7):2751-8. PubMed ID: 10914720 [TBL] [Abstract][Full Text] [Related]
18. Inhibitors of apoptosis proteins in human cervical cancer. Espinosa M; Cantú D; Herrera N; Lopez CM; De la Garza JG; Maldonado V; Melendez-Zajgla J BMC Cancer; 2006 Feb; 6():45. PubMed ID: 16504151 [TBL] [Abstract][Full Text] [Related]
19. Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen. Bertheau P; Turpin E; Rickman DS; Espié M; de Reyniès A; Feugeas JP; Plassa LF; Soliman H; Varna M; de Roquancourt A; Lehmann-Che J; Beuzard Y; Marty M; Misset JL; Janin A; de Thé H PLoS Med; 2007 Mar; 4(3):e90. PubMed ID: 17388661 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer. Moniri Javadhesari S; Gharechahi J; Hosseinpour Feizi MA; Montazeri V; Halimi M Genet Test Mol Biomarkers; 2013 Apr; 17(4):314-20. PubMed ID: 23368531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]